Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...
Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
SAN DIEGO—Cytiva has launched its Sefia next-generation manufacturing platform, with the goal of helping drug developers and larger healthcare providers accelerate their production of chimeric antigen ...
Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, ...
Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...
When most people think of cancer care, they rarely associate it with what goes on behind the scenes to create life-saving treatments. For starters, developing cell and gene therapies is pricey, and ...
A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...
Emily Whitehead made the history books in 2012 when she become the first pediatric patient with B-cell acute lymphoblastic leukemia to be given a chimeric antigen receptor (CAR) T-cell therapy. After ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results